BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23704897)

  • 21. Transgenic pigs expressing human decay-accelerating factor regulated by porcine MCP gene promoter.
    Murakami H; Nagashima H; Takahagi Y; Miyagawa S; Fujimura T; Toyomura K; Nakai R; Yamada M; Kurihara T; Shigehisa T; Okabe M; Seya T; Shirakura R; Kinoshita T
    Mol Reprod Dev; 2002 Mar; 61(3):302-11. PubMed ID: 11835575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transgenic mice designed to express human alpha-1,2-fucosyltransferase in combination of human DAF and CD59 to avoid xenograft rejection.
    Liu B; Cheng C; Wu Y; Wei J; Li G; Ma T
    Sci China C Life Sci; 2008 Mar; 51(3):199-204. PubMed ID: 18246307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced sensitivity to human serum inactivation of enveloped viruses produced by pig cells transgenic for human CD55 or deficient for the galactosyl-alpha(1-3) galactosyl epitope.
    Magre S; Takeuchi Y; Langford G; Richards A; Patience C; Weiss R
    J Virol; 2004 Jun; 78(11):5812-9. PubMed ID: 15140979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of human CD59 in transgenic pig organs enhances organ survival in an ex vivo xenogeneic perfusion model.
    Kroshus TJ; Bolman RM; Dalmasso AP; Rollins SA; Guilmette ER; Williams BL; Squinto SP; Fodor WL
    Transplantation; 1996 May; 61(10):1513-21. PubMed ID: 8633381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis of three genetic modifications designed to inhibit human serum-mediated cytolysis.
    Costa C; Zhao L; Decesare S; Fodor WL
    Xenotransplantation; 1999 Feb; 6(1):6-16. PubMed ID: 10355728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP.
    Huang J; Gou D; Zhen C; Jiang D; Mao X; Li W; Chen S; Cai C
    FEMS Immunol Med Microbiol; 2001 Oct; 31(3):203-9. PubMed ID: 11720816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of hyperacute rejection in a model of orthotopic liver xenotransplantation from pig to baboon using polytransgenic pig livers (CD55, CD59, and H-transferase).
    Ramírez P; Montoya MJ; Ríos A; García Palenciano C; Majado M; Chávez R; Muñoz A; Fernández OM; Sánchez A; Segura B; Sansano T; Acosta F; Robles R; Sánchez F; Fuente T; Cascales P; González F; Ruiz D; Martínez L; Pons JA; Rodríguez JI; Yélamos J; Cowan P; d'Apice A; Parrilla P
    Transplant Proc; 2005 Nov; 37(9):4103-6. PubMed ID: 16386637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenovirus-mediated expression of human CD55 or CD59 protects adult porcine islets from complement-mediated cell lysis by human serum.
    Schmidt P; Goto M; Le Mauff B; Anegon I; Korsgren O
    Transplantation; 2003 Mar; 75(5):697-702. PubMed ID: 12640312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained function of genetically modified porcine lungs in an ex vivo model of pulmonary xenotransplantation.
    Westall GP; Levvey BJ; Salvaris E; Gooi J; Marasco S; Rosenfeldt F; Egan C; McEgan Ccp R; Mennen M; Russell P; Robson SC; Nottle MB; Dwyer KM; Snell GI; Cowan PJ
    J Heart Lung Transplant; 2013 Nov; 32(11):1123-30. PubMed ID: 23932853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection of xenogeneic cardiac endothelium from human complement by expression of CD59 or DAF in transgenic mice.
    Byrne GW; McCurry KR; Kagan D; Quinn C; Martin MJ; Platt JL; Logan JS
    Transplantation; 1995 Nov; 60(10):1149-56. PubMed ID: 7482724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of the human alpha1,2-fucosyltransferase in transgenic pigs modifies the cell surface carbohydrate phenotype and confers resistance to human serum-mediated cytolysis.
    Costa C; Zhao L; Burton WV; Bondioli KR; Williams BL; Hoagland TA; Ditullio PA; Ebert KM; Fodor WL
    FASEB J; 1999 Oct; 13(13):1762-73. PubMed ID: 10506579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strong xenoprotective function by single-copy transgenes placed sequentially at a permissive locus.
    Rieblinger B; Fischer K; Kind A; Saller BS; Baars W; Schuster M; Wolf-van Buerck L; Schäffler A; Flisikowska T; Kurome M; Zakhartchenko V; Kessler B; Flisikowski K; Wolf E; Seissler J; Schwinzer R; Schnieke A
    Xenotransplantation; 2018 Mar; 25(2):e12382. PubMed ID: 29359453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient generation of GGTA1-null Diannan miniature pigs using TALENs combined with somatic cell nuclear transfer.
    Cheng W; Zhao H; Yu H; Xin J; Wang J; Zeng L; Yuan Z; Qing Y; Li H; Jia B; Yang C; Shen Y; Zhao L; Pan W; Zhao HY; Wang W; Wei HJ
    Reprod Biol Endocrinol; 2016 Nov; 14(1):77. PubMed ID: 27821126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production of genetically modified porcine blastocysts by somatic cell nuclear transfer: preliminary results toward production of xenograft-competent miniature pigs.
    Himaki T; Watanabe S; Chi H; Yoshida M; Miyoshi K; Sato M
    J Reprod Dev; 2010 Dec; 56(6):630-8. PubMed ID: 20814171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effects of different combinations of human MCP, DAF, and CD59 on complement-dependent cytolysis in NIH 3T3 cells.
    Yang X; Deng J; Jiang Z; Liao DJ; Jiang H
    Exp Clin Transplant; 2012 Feb; 10(1):49-54. PubMed ID: 22309420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knock out of alpha1,3-galactosyltransferase or expression of alpha1,2-fucosyltransferase further protects CD55- and CD59-expressing mouse hearts in an ex vivo model of xenograft rejection.
    Cowan PJ; Chen CG; Shinkel TA; Fisicaro N; Salvaris E; Aminian A; Romanella M; Pearse MJ; d'Apice AJ
    Transplantation; 1998 Jun; 65(12):1599-604. PubMed ID: 9665076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-level co-expression of complement regulators on vascular endothelium in transgenic mice: CD55 and CD59 provide greater protection from human complement-mediated injury than CD59 alone.
    Cowan PJ; Shinkel TA; Aminian A; Romanella M; Wigley PL; Lonie AJ; Nottle MB; Pearse MJ; d'Apice AJ
    Xenotransplantation; 1998 Aug; 5(3):184-90. PubMed ID: 9741456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production of human CD59-transgenic pigs by embryonic germ cell nuclear transfer.
    Ahn KS; Won JY; Park JK; Sorrell AM; Heo SY; Kang JH; Woo JS; Choi BH; Chang WK; Shim H
    Biochem Biophys Res Commun; 2010 Oct; 400(4):667-72. PubMed ID: 20816662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pigs transgenic for human thrombomodulin have elevated production of activated protein C.
    Petersen B; Ramackers W; Tiede A; Lucas-Hahn A; Herrmann D; Barg-Kues B; Schuettler W; Friedrich L; Schwinzer R; Winkler M; Niemann H
    Xenotransplantation; 2009; 16(6):486-95. PubMed ID: 20042048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient production of multi-modified pigs for xenotransplantation by 'combineering', gene stacking and gene editing.
    Fischer K; Kraner-Scheiber S; Petersen B; Rieblinger B; Buermann A; Flisikowska T; Flisikowski K; Christan S; Edlinger M; Baars W; Kurome M; Zakhartchenko V; Kessler B; Plotzki E; Szczerbal I; Switonski M; Denner J; Wolf E; Schwinzer R; Niemann H; Kind A; Schnieke A
    Sci Rep; 2016 Jun; 6():29081. PubMed ID: 27353424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.